Hikma Pharmaceuticals

Hikma Pharmaceuticals plc is a British multinational pharmaceutical company with headquarters in London, UK that manufactures non-branded generic and in-licensed pharmaceutical products. It was founded by Samih Darwazah in Amman, Jordan in 1978. It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Abiraterone	Abiraterone	2018-10-31	2027-2038	Castration-resistant prostatic neoplasms , Prostatic neoplasms
Acarbose	Acarbose	2008-05-07		Type 2 diabetes mellitus
Acetaminophen	Acetaminophen	2016-06-13	2025-2039	Fever , Pain
Acetazolamide	Acetazolamide	1995-02-28		Altitude sickness, Glaucoma, Seizures
Acyclovir	Acyclovir	2005-06-07	2027-2030	Aids-related opportunistic infections, Chickenpox, Epstein-barr virus infections, Herpes genitalis, Herpes labialis, Herpes simplex, Herpes simplex encephalitis, Herpes zoster, Herpes zoster ophthalmicus
Adenosine	Adenosine	2004-06-16		—
Alendronate	Alendronate	2013-02-25	2031	Postmenopausal osteoporosis, Extramammary paget disease
Allopurinol	Allopurinol	2004-08-26	2025-2032	Gout
Alosetron	Alosetron	2015-05-04		Abdominal pain, Diarrhea, Irritable bowel syndrome
Alprazolam	Alprazolam	1993-10-31		Agoraphobia, Depressive disorder, Panic disorder
Alprostadil	Alprostadil	1998-01-20		Aortic arch syndromes, Aortic coarctation, Hypoplastic left heart syndrome, Patent ductus arteriosus, Pulmonary hypertension, Pulmonary valve stenosis, Tetralogy of fallot, Tricuspid atresia, Vasculogenic impotence